Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02748395

Enrollment

Registered

2016-04-22

Start date

2016-05-31

Completion date

Unknown

Last updated

2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Cutaneous Nerve Entrapment Syndrome, Chronic Abdominal Wall Pain

Brief summary

The purpose of this study is to determine whether the injection of triamcinolone and lidocaine is effective in relieving chronic abdominal wall pain.

Interventions

DRUGTriamcinolone

OTHERPlacebo

DRUGLidocaine

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of chronic abdominal wall pain * Prior ultrasound or cross-sectional imaging of the abdomen to exclude other causes * Baseline Brief Pain Inventory score ≥ 5

Exclusion criteria

* Multiple trigger points * Abdominal wall hernia on exam * Weight loss * Rectal bleeding * Recent change in bowel habits * Decompensated cirrhosis or recurrent ascites * Allergy or contraindication to study medications * Known thrombocytopenia with platelet count \< 50,000 * Other diagnosis of chronic pain syndromes including fibromyalgia * Unable to provide informed consent * Pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Pain score	Baseline and 1 month	Questionnaire to assess change in pain score

Secondary

Measure	Time frame	Description
Pain score	Baseline and 1 week	Questionnaire to assess change in pain score

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026